Regenerative Medicine Foundation
  • Leadership
  • What We Do
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • World Stem Cell Summit
    • Regenerative Medicine Essentials
    • The “Art of Science” Inspires Students
    • Exploring Public Policy: Regenerative Medicine and Cell Therapies
    • Congressional Briefings
    • Regenerative Medicine and Stem Cell Action Awards
    • World Stem Cell Summit – CHINA
  • Membership/Register
    • Membership – Register for WSCS and RME Course
    • Donate
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact
Select Page

Aging Frailty with Influenza Vaccine Trial announced by Longeveron

by Kevin McMahon | Jan 21, 2018 | News & Opinions, Science

America is facing one of the worst influenza seasons in recent history. The influenza virus is one of the top ten causes of death in elderly people. Longeveron is conducting a multi-center, randomized, placebo controlled trial using its Longeveron Mesenchymal Stem...

Recent Posts

  • Repeated injury to airway stem cells could be major factor in chronic lung disease
  • What’s next for lab-grown human embryos?
  • New Hope for Muscle-Related Diseases? Converting skin cells to immature muscle cells spurs changes, study finds
  • Scientists develop brain organoids with complex neural activity
  • Phase 1 clinical study reveals how stem cells alleviate COPD inflammation in humans
Tweets about @WSCSummit
CC Regenerative Medicine Foundation